Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Mediq NV (MEDIQ) : Company Profile and SWOT Analysis
Publication Date Jul 2012
Publisher World Market Intelligence
Product Type Report
Pages 38
Single User License $ 120.00
Site User License $ 240.00
Corporate User License $ 360.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'Mediq NV (MEDIQ) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
• Examines and identifies key information and issues about 'Mediq NV' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees

Reasons to Buy
• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Key Highlights
Mediq NV (Mediq), formerly known as OPG Groe, is a healthcare company based in the Netherlands. The company is a retailer and distributor of pharmaceuticals and medical products. The company delivers medical devices along with information, instruction and nursing care directly to customers. It provides wound treatment, respiratory therapy, enteral nutrition, infusion therapy and biotech pharmaceuticals. The company also provides consultation, training, and support in inventory management, cost control and standardization. The company operates 423 pharmacies in Netherlands and Poland. Furthermore, through its subsidiaries, the company offers medical supplies across Poland, Belgium, Norway, the Netherlands, Hungary, the US, Germany, Denmark and Switzerland. Mediq is headquartered in Utrecht, the Netherlands.


Companies Mentioned

Mediq NV

1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset and Liabilities
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Operational Efficiency
2.2.5 Solvency
2.2.6 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Turnover – Inventory and Asset
2.3.4 Liquidity
3 Mergers & Acquisitions and Partnerships
3.1 M&A and Partnerships Strategy
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 Company Statement
6 History
7 Key Employees
8 Key Employee Biographies
9 Locations and Subsidiaries
9.1 Head Office
9.2 Other Locations and Subsidiaries
10 Appendix
10.1 Methodology
10.2 Ratio Definitions
10.3 Disclaimer

List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries

List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Operational Efficiency
Figure 5: Solvency
Figure 6: Valuation
Figure 7: Market Capitalization
Figure 8: Efficiency
Figure 9: Turnover – Inventory and Asset
Figure 10: Liquidity

Title Date Price
3DM Inc. - Strategic SWOT Analysis Review
By GlobalData
3DM Inc. - Strategic SWOT Analysis ReviewSummary3DM Inc. (3DM) is a privately held specialty biomaterials and medical device company. It is a subsidiary of 3D-Matrix, Ltd, Japan. The company develops ...Read More
Aug 2011 $125.00
3M ESPE Dental Products Market Share Analysis
By GlobalData
3M ESPE Dental Products Market Share AnalysisSummaryGlobalData’s new report, “3M ESPE Dental Products Market Share Analysis” provides in-depth information on 3M ESPE Dental Products’s market p ...Read More
Feb 2013 $1000.00
3M Health Care - Strategic SWOT Analysis Review
By GlobalData
3M Health Care - Strategic SWOT Analysis ReviewSummary3M Health Care, a business segment of 3M Company, provides medical and oral care products, drug delivery and health information systems worldwide. ...Read More
Aug 2011 $125.00
3SBio Inc. (SSRX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary3SBio Inc. (3S Bio) is a biotechnology company with focus on the research and development, manufacturing and marketing of biopharmaceutical products in China. It develops recombinant, or geneti ...Read More
Apr 2013 $125.00
3Shape A/S. Market Share Analysis
By GlobalData
3Shape A/S. Market Share AnalysisSummaryGlobalData’s new report, “3Shape A/S. Market Share Analysis” provides in-depth information on 3Shape A/S.’s market position in the CAD/CAM dental system ...Read More
Nov 2012 $1000.00
3WIN nv - Product Pipeline Analysis
By GlobalData
3WIN nv - Product Pipeline AnalysisSummary3WIN nv (3WIN) is engaged in the development and marketing of active implantable medical devices. The company is developing a deep brain stimulator (DBS), whi ...Read More
Oct 2011 $750.00
4SC AG (VSC) - Financial and Strategic SWOT Analysis Review
By GlobalData
4SC AG (VSC) - Financial and Strategic SWOT Analysis ReviewSummary4SC AG is a Germany based research oriented company which concentrates mainly on the discovery of the drugs as well as its development ...Read More
Aug 2011 $125.00
572-Trii (HIV) - Forecast and Market Analysis to 2022
By GlobalData
572-Trii (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “572-Trii (HIV) - Forecast and Market Analysis to ...Read More
Mar 2013 $3995.00
A&G Pharmaceutical, Inc. - Product Pipeline Analysis
By GlobalData
SummaryA&G Pharmaceutical, Inc. (A&G) is a pharmaceutical company, based in the US. The company develops therapeutic and diagnostic products for the in-vitro diagnostic markets. Its products include b ...Read More
Nov 2012 $750.00
A-dec Inc. GmbH Market Share Analysis
By GlobalData
A-dec Inc. GmbH Market Share AnalysisSummaryGlobalData’s new report, “A-dec Inc. GmbH Market Share Analysis” provides in-depth information on A-dec Inc..’s market position in the dental device ...Read More
Jan 2013 $1000.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   
   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9425069161
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z